Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment
Explore this paper's citation graph
Summary
Data indicate that in early stages of Alzheimer's Disease, AD may be characterized by a more lateralized pattern of left hemispheric rCMRgl declines, however, metabolic differences between hemispheres appear to diminish with further progression of the disease.
- Type
- article
- Published
- 2018-07-17
- Cited by
- 86
- References
- 55
- Access
- Open access
- OpenAlex
- https://openalex.org/W2883139774
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:49863829
Keywords
Lateralization of brain function, Dementia, Positron emission tomography, Neuroimaging, Alzheimer's Disease Neuroimaging Initiative
References
- Changes in brain functional homogeneity in subjects with Alzheimer's disease.
- [The logopenic variant of primary progressive aphasia].
- Grey-Matter Atrophy in Alzheimer's Disease is Asymmetric but not Lateralized
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician
- Atrophy Patterns in Early Clinical Stages Across Distinct Phenotypes of Alzheimer’s Disease
- A new rating scale for Alzheimer's disease.
- Mechanisms of Protein Seeding in Neurodegenerative Diseases
- Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization
- Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease
- Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.
- Asymmetry of pathology in Alzheimer's disease.
- FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type
- Glucose metabolism in normal aging and Alzheimer’s disease: Methodological and physiological considerations for PET studies
- FDG-PET and amyloid-PET imaging: the diverging paths.
- Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs: Additions to the Alzheimer's Disease Assessment Scale That Broaden Its Scope
- Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease.
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- Relations between Neuropsychological and Cerebral Metabolic Asymmetries in Early Alzheimer's Disease
- Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.
- BRAIN IMAGING IN THE STUDY OF ALZHEIMER'S DISEASE
Cited by
- Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer’s disease and mild cognitive impairment
- Oxidative stress, dysfunctional glucose metabolism, and Alzheimer disease
- Activated peripheral blood mononuclear cell mediators trigger astrocyte reactivity.
- History and progress of hypotheses and clinical trials for Alzheimer’s disease
- Differential Regional Brain Spontaneous Activity in Subgroups of Mild Cognitive Impairment
- Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease
- Glucose, glycolysis, and neurodegenerative diseases
- Medial temporal lobe connectivity and its associations with cognition in early Alzheimer’s disease
- A Graph Gaussian Embedding Method for Predicting Alzheimer’s Disease Progression with MEG Brain Networks
- Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
- Asymmetric Differences in the Gray Matter Volume and Functional Connections of the Amygdala Are Associated With Clinical Manifestations of Alzheimer’s Disease
- Aberrant White Matter Microstructure as a Potential Diagnostic Marker in Alzheimer's Disease by Automated Fiber Quantification
- Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models
- Effects of a Nutritional Formulation Containing Caprylic and Capric Acid, Phosphatidylserine, and Docosahexaenoic Acid in Streptozotocin-Lesioned Rats
- Pathological Correlations of Neuropsychiatric Symptoms in Institutionalized People with Dementia
- Lateralized memory circuit dropout in Alzheimer’s disease patients
- Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
- Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer’s Disease
- Mapping of impaired functional connectivity during memory phases in Alzheimer's disease and its association with cortical β-amyloid
- Asymmetric Amyloid Deposition as an Early Sign of Progression in Mild Cognitive Impairment Due to Alzheimer Disease
Related papers
- Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change?
- The Alzheimer’s Disease Neuroimaging Initiative: Progress report and future plans
- O3‐09‐01: PROTECTIVE EFFECT OF PHYSICAL ACTIVITY ON LONGITUDINAL COGNITIVE DECLINE AND NEURODEGENERATION IN CLINICALLY NORMAL OLDER ADULTS WITH ELEVATED β‐AMYLOID BURDEN
- Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients
- Association of plasma and cortical beta-amyloid is modulated by APOE ε4 status
- Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease
- Sex, Amyloid, and APOEε4 and risk of cognitive decline in preclinical Alzheimer’s disease: findings from three well-characterized cohorts
- P1–071: Genetic and imaging biomarkers predicting beta‐amyloid amyloid–related cognitive decline using the Alzheimer's Disease Neuroimaging Initiative data
- 66 Brain imaging in early detection of Alzheimer's disease and other dementias